Park Chulhun, Vo Chau Le-Ngoc, Kang Taehee, Oh Euichaul, Lee Beom-Jin
College of Pharmacy, Ajou University, Suwon, Republic of Korea.
College of Pharmacy, The Catholic University, Bucheon, Republic of Korea.
Eur J Pharm Biopharm. 2015 Jan;89:365-73. doi: 10.1016/j.ejpb.2014.12.002. Epub 2014 Dec 20.
In this study, we investigated a new method for the preparation of gelatin-oleic conjugate (GOC) as an amphiphilic biomaterial to load model anti-cancer drugs into self-assembled nanoparticles (NPs). Oleic acid (OA) was covalently bound to gelatin via carbodiimide/N-hydroxysuccinimide (EDC/NHS) reaction in water-ethanol cosolvent to form a GOC. Fourier transform infrared (FT-IR) spectroscopy and proton nuclear magnetic resonance ((1)H NMR) clearly indicated the successful synthesis of GOC. The percentage of gelatin amino groups reacted with OA was up to 50% as determined using the 2,4,6-trinitrobenzene sulfonic acid (TNBS) method. Subsequently, gelatin-oleic nanoparticles (GONs) were prepared using a desolvation method with glutaraldehyde or genipin used as a crosslinker for comparison. Irinotecan hydrochloride (IRT) was used as a model drug to load into GONs using incubation or an in-process adding method for comparison. Dynamic light scattering (DLS) and transmission electron microscopy (TEM) data showed that the sizes of GONs and IRT-loaded GONs (IRT-GONs) were below 250 nm. The zeta potentials of the GONs and irinotecan-loaded IRT-GONs were below -20 mV, which was found to be stable in suspension against the aggregation process. The incubation method was more suitable for drug loading because it did not affect the process of GON formation and thus did not increase their size much compared to the change in size with the in-process adding method. The lipophilic property of the oleic moiety in the GOC increased the affinity between GOC molecules, thus reducing the amount of crosslinking agents needed to stabilize GONs compared to gelatin nanoparticles (GNs). As novel approaches for the synthesis of protein-fatty acid complexes, chemical reaction has been suggested for the synthesis of GOC. The above results show that GOC synthesized via new method is a promising biomaterial based upon preparation of nanoparticles.
在本研究中,我们研究了一种制备明胶 - 油酸共轭物(GOC)的新方法,GOC作为一种两亲性生物材料,可将模型抗癌药物负载到自组装纳米颗粒(NPs)中。油酸(OA)通过碳二亚胺/N-羟基琥珀酰亚胺(EDC/NHS)反应在水 - 乙醇共溶剂中与明胶共价结合,形成GOC。傅里叶变换红外(FT-IR)光谱和质子核磁共振((1)H NMR)清楚地表明成功合成了GOC。使用2,4,6-三硝基苯磺酸(TNBS)法测定,与OA反应的明胶氨基百分比高达50%。随后,使用去溶剂化方法制备明胶 - 油酸纳米颗粒(GONs),并使用戊二醛或京尼平作为交联剂进行比较。盐酸伊立替康(IRT)用作模型药物,通过孵育法或过程中添加法将其负载到GONs中进行比较。动态光散射(DLS)和透射电子显微镜(TEM)数据表明,GONs和负载IRT的GONs(IRT-GONs)的尺寸均低于250 nm。GONs和负载伊立替康的IRT-GONs的zeta电位低于 -20 mV,发现在悬浮液中对聚集过程稳定。孵育法更适合药物负载,因为它不影响GON的形成过程,因此与过程中添加法相比,其尺寸增加幅度不大。GOC中油酸部分的亲脂性增加了GOC分子之间的亲和力,因此与明胶纳米颗粒(GNs)相比,稳定GONs所需的交联剂数量减少。作为合成蛋白质 -脂肪酸复合物的新方法,已提出通过化学反应合成GOC。上述结果表明,通过新方法合成的GOC是一种基于纳米颗粒制备的有前途的生物材料。